Keck School Faculty

Brian Kim

Brian Kim

Clinical Associate Professor of Medicine (Clinician Educator)
Medicine
HCC 251 1510 San Pablo Street Mail Code:9198 Health Sciences Campus Los Angeles

University of Southern California: USC Transplant Hepatology Faculty Teacher of the Year, 2021-2022

American Liver Foundation: American Liver Foundation (ALF) Liver Health Poster Competition Winner, 2021

University of Southern California: USC Internal Medicine Residency Subspecialty Faculty Teacher of the Year, 2018-2019

University of Southern California: USC Internal Medicine Residency Subspecialty Faculty Teacher of the Year, 2016-2017

University of Southern California: USC Division of Gastrointestinal and Liver Diseases Faculty Teacher of the Year, 2015-2016

American Association for the Study of Liver Diseases: Advanced/Transplant Hepatology Fellowship Award, 2013

American College of Gastroenterology: Presidential Poster Award, 2011

: Falcon Award for Patient Care, 2010

Columbia Residency Program: Hospitalist Resident of the Year, 2009

: Louis and Rachel Rudin Scholar, 2004-2006

Scholar: Ewha University Alumnae Association, 2003-2004

USA Funds Access to Education: Scholar, 2002-2006

: Phi Beta Kappa, 2002

Yale University : Summa Cum Laude, 2002

: William Grey Warden Scholar, 2001-2002

Theodore F. Myers and Margaret B Myers: Scholar, 1999-2000

: Robert C. Byrd Scholar, 1998-2002

Yale Club of Chicago Foundation: Scholar, 1998-1999

: National Merit Scholar, 1998-1999

Optimizing Hepatology Education in the Virtual World Clin Liver Dis (Hoboken). 2022 Apr; 19(4):139-143. . View in PubMed

The translational revolution of itch Neuron. 2022 07 20; 110(14):2209-2214. . View in PubMed

Transfusion-free Retransplantation for Post-liver Transplantation Hepatic Artery Thrombosis: How Much Augmentation Is Too Much? Transplant Direct. 2021 Nov; 7(11):e776.. View in PubMed

Autoimmune hepatitis triggered by COVID-19 Intern Med J. 2021 Jul; 51(7):1182-1183. . View in PubMed

Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures Eur J Gastroenterol Hepatol. 2021 04 01; 33(4):541-546. . View in PubMed

Associating filaggrin copy number variation and atopic dermatitis in African-Americans: Challenges and opportunities J Dermatol Sci. 2020 Apr; 98(1):58-60. . View in PubMed

Treatment and Outcomes of Early Stage Breast Cancer in Patients with Hepatic Dysfunction J Surg Res. 2020 12; 256:212-219. . View in PubMed

Liver transplantation as therapy for hepatocellular carcinoma Liver Int. 2020 02; 40 Suppl 1:116-121. . View in PubMed

A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma Case Rep Endocrinol. 2019; 2019:4601484. . View in PubMed

Incidental Coronary Artery Calcification Seen on Low-Dose Computed Tomography Is a Risk Factor for Obstructive Coronary Artery Disease in Patients Undergoing Liver Transplant Transplant Proc. 2018 Dec; 50(10):3487-3495. . View in PubMed

Patent foramen ovale and neurologic events in patients undergoing liver transplantation Cardiovasc Revasc Med. 2018 09; 19(6S):53-55. . View in PubMed

Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA Dig Dis Sci. 2018 05; 63(5):1327-1333. . View in PubMed

Risk and Prognosis of Acute Liver Injury Among Hospitalized Patients with Hemodynamic Instability: A Nationwide Analysis Ann Hepatol. 2018 January-February; 17(1):119-124. . View in PubMed

Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver TransplantationGastroenterology. 2017 02; 152(3):550-553. e8. . View in PubMed

Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation Clin Transplant. 2016 May; 30(5):579-88. . View in PubMed

Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy J Neurosurg. 2016 12; 125(Suppl 1):40-49. . View in PubMed

Comparison of outcome in patients with versus without ascites referred for either cardiac transplantation or ventricular assist device placement Am J Cardiol. 2015 Nov 15; 116(10):1596-600. . View in PubMed

Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation Transplant Direct. 2015 Jul; 1(6):e21. . View in PubMed

Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms Dig Dis Sci. 2014 Aug; 59(8):1817-22. . View in PubMed

Case report of successful treatment of fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin after liver transplantation Semin Liver Dis. 2014 Feb; 34(1):108-12. . View in PubMed

Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature Dig Dis Sci. 2013 May; 58(5):1185-90. . View in PubMed

Chemoprevention in familial adenomatous polyposis Best Pract Res Clin Gastroenterol. 2011 Aug; 25(4-5):607-22. . View in PubMed

Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease J Neurol Neurosurg Psychiatry. 2006 Jan; 77(1):12-7. . View in PubMed

Microelectrode recording-determined subthalamic nucleus length not predictive of stimulation-induced side effects Neurosurg Focus. 2005 Nov 15; 19(5):E13. . View in PubMed

Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy Clin Prostate Cancer. 2004 Sep; 3(2):93-7. . View in PubMed

Dr. Brian Kim is a transplant hepatologist specializing in the treatment of patients with acute and chronic liver disease, cirrhosis, and hepatocellular carcinoma. Dr. Kim is board certified in internal medicine, gastroenterology, and transplant hepatology. He is an active member of the American Association for the Study of Liver Diseases (AASLD) where he serves as a member of the AASLD Training and Workforce Committee. He is also an active member of the American College of Gastroenterology.

Dr. Kim’s clinical research interests include liver transplantation, living donor liver transplantation, cardiac diseases in liver patients, and complications of portal hypertension. He has authored numerous chapters and articles in peer-reviewed journals on various topics in liver disease, liver transplantation, and education.

He currently serves as the Program Director for the ACGME-accredited Gastroenterology and Hepatology Fellowship at USC and also serves as the chair of the USC Keck School of Medicine GI/Liver Course.
He graduated with a Bachelor of Science in molecular, cellular, and developmental biology from Yale University. He received his MD from Columbia University College of Physicians and Surgeons. He completed his internship and residency training in internal medicine at Columbia University New York-Presbyterian Hospital. He then completed gastroenterology fellowship training at Johns Hopkins University School of Medicine and transplant hepatology fellowship training at Mount Sinai School of Medicine.
sc ctsi logoPowered by SC CTSI